PortfoliosLab logoPortfoliosLab logo
PJP vs. RSP
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

PJP vs. RSP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Invesco Dynamic Pharmaceuticals ETF (PJP) and Invesco S&P 500 Equal Weight ETF (RSP). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, PJP achieves a 2.90% return, which is significantly lower than RSP's 9.70% return. Over the past 10 years, PJP has underperformed RSP with an annualized return of 6.15%, while RSP has yielded a comparatively higher 11.86% annualized return.


PJP

1D
1.20%
1M
1.29%
YTD
2.90%
6M
2.29%
1Y
34.73%
3Y*
13.31%
5Y*
7.62%
10Y*
6.15%

RSP

1D
-0.38%
1M
3.77%
YTD
9.70%
6M
10.18%
1Y
19.50%
3Y*
15.23%
5Y*
8.33%
10Y*
11.86%
*Multi-year figures are annualized to reflect compound growth (CAGR)

PJP vs. RSP - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
PJP
Invesco Dynamic Pharmaceuticals ETF
2.90%27.98%9.63%-2.18%-2.16%14.58%11.29%4.64%-1.78%15.30%
RSP
Invesco S&P 500 Equal Weight ETF
9.70%11.21%12.79%13.70%-11.62%29.41%12.66%28.91%-7.84%18.52%

Correlation

The correlation between PJP and RSP is 0.50, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.50

Correlation (3Y)
Calculated over the trailing 3-year period

0.59

Correlation (5Y)
Calculated over the trailing 5-year period

0.62

Correlation (10Y)
Calculated over the trailing 10-year period

0.63

Correlation (All Time)
Calculated using the full available price history since Jun 24, 2005

0.68

The correlation between PJP and RSP shifts across timeframes, from 0.50 (1 year) to 0.68 (all time), reflecting how their relationship changes across market environments.

PJP vs. RSP - Sectors Allocation Comparison


Sectors
PJP
RSP

Healthcare

100.0%
11.0%

Basic Materials

-

4.1%

Communication Services

-

3.7%

Consumer Cyclical

-

9.9%

Consumer Defensive

-

6.5%

Energy

-

4.5%

Financial Services

-

14.5%

Industrials

-

14.1%

Real Estate

-

6.0%

Technology

-

19.6%

Utilities

-

6.1%

Healthcare

PJP
100.0%
RSP
11.0%

Basic Materials

PJP

-

RSP
4.1%

Communication Services

PJP

-

RSP
3.7%

Consumer Cyclical

PJP

-

RSP
9.9%

Consumer Defensive

PJP

-

RSP
6.5%

Energy

PJP

-

RSP
4.5%

Financial Services

PJP

-

RSP
14.5%

Industrials

PJP

-

RSP
14.1%

Real Estate

PJP

-

RSP
6.0%

Technology

PJP

-

RSP
19.6%

Utilities

PJP

-

RSP
6.1%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PJP vs. RSP — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PJP
PJP Risk / Return Rank: 6464
Overall Rank
PJP Sharpe Ratio Rank: 6363
Sharpe Ratio Rank
PJP Sortino Ratio Rank: 6464
Sortino Ratio Rank
PJP Omega Ratio Rank: 5757
Omega Ratio Rank
PJP Calmar Ratio Rank: 7373
Calmar Ratio Rank
PJP Martin Ratio Rank: 6363
Martin Ratio Rank

RSP
RSP Risk / Return Rank: 4949
Overall Rank
RSP Sharpe Ratio Rank: 4848
Sharpe Ratio Rank
RSP Sortino Ratio Rank: 4949
Sortino Ratio Rank
RSP Omega Ratio Rank: 4646
Omega Ratio Rank
RSP Calmar Ratio Rank: 5050
Calmar Ratio Rank
RSP Martin Ratio Rank: 5454
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PJP vs. RSP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Invesco Dynamic Pharmaceuticals ETF (PJP) and Invesco S&P 500 Equal Weight ETF (RSP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


PJPRSPDifference
Sharpe ratioReturn per unit of total volatility

+0.43

Sortino ratioReturn per unit of downside risk

+0.54

Omega ratioGain probability vs. loss probability

1.36

1.30

+0.06

Calmar ratioReturn relative to maximum drawdown

3.70

2.49

+1.20

Martin ratioReturn relative to average drawdown

11.55

9.48

+2.07

PJP vs. RSP - Sharpe Ratio Comparison

The current PJP Sharpe Ratio is 2.13, which is comparable to the RSP Sharpe Ratio of 1.70. The chart below compares the historical Sharpe Ratios of PJP and RSP, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


PJPRSPDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.13

1.70

+0.43

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.47

0.52

-0.04

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.34

0.65

-0.31

Sharpe Ratio (All Time)

Calculated using the full available price history

0.59

0.57

+0.02

Drawdowns

PJP vs. RSP - Drawdown Comparison

The maximum PJP drawdown since its inception was -37.06%, smaller than the maximum RSP drawdown of -59.92%. Use the drawdown chart below to compare losses from any high point for PJP and RSP.


Loading charts...

Drawdown Indicators


PJPRSPDifference

Max Drawdown

Largest peak-to-trough decline

-37.06%

-59.92%

+22.86%

Max Drawdown (1Y)

Largest decline over 1 year

-9.44%

-7.85%

-1.59%

Max Drawdown (3Y)

Largest decline over 3 years

-16.27%

-17.81%

+1.54%

Max Drawdown (5Y)

Largest decline over 5 years

-17.51%

-21.38%

+3.87%

Max Drawdown (10Y)

Largest decline over 10 years

-33.95%

-39.04%

+5.09%

Current Drawdown

Current decline from peak

-2.94%

-0.38%

-2.56%

Average Drawdown

Average peak-to-trough decline

-8.85%

-6.65%

-2.20%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.02%

2.06%

+0.96%

Volatility

PJP vs. RSP - Volatility Comparison

Invesco Dynamic Pharmaceuticals ETF (PJP) has a higher volatility of 5.33% compared to Invesco S&P 500 Equal Weight ETF (RSP) at 2.56%. This indicates that PJP's price experiences larger fluctuations and is considered to be riskier than RSP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


PJPRSPDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.33%

2.56%

+2.77%

Volatility (6M)

Calculated over the trailing 6-month period

12.02%

8.29%

+3.73%

Volatility (1Y)

Calculated over the trailing 1-year period

16.38%

11.56%

+4.82%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

16.17%

16.18%

-0.01%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

18.39%

18.35%

+0.04%

PJP vs. RSP - Expense Ratio Comparison

PJP has a 0.58% expense ratio, which is higher than RSP's 0.20% expense ratio.


Dividends

PJP vs. RSP - Dividend Comparison

PJP's dividend yield for the trailing twelve months is around 0.99%, less than RSP's 1.49% yield.


PositionTTM20252024202320222021202020192018201720162015
PJP
Invesco Dynamic Pharmaceuticals ETF
0.99%0.98%0.97%1.01%0.95%0.81%0.75%0.77%1.12%0.65%0.91%5.49%
RSP
Invesco S&P 500 Equal Weight ETF
1.49%1.64%1.52%1.64%1.82%1.28%1.64%1.69%2.02%1.52%1.20%1.70%

Frequently Asked Questions


PJP and RSP have a correlation of 0.50, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

PJP has higher volatility (5.33%) compared to RSP (2.56%). In terms of maximum drawdown, PJP dropped -37.06% vs RSP's -59.92%.

On 10-year performance, RSP leads with 11.86% vs 6.15% for PJP. On fees, RSP is cheaper at 0.20% per year. On volatility, RSP has been the lower-risk option at 2.56%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, RSP has performed better with a 11.86% return vs 6.15%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

RSP is cheaper with a 0.20% expense ratio, compared with 0.58% for PJP.

RSP has the higher dividend yield at 1.49%, compared with 0.99% for PJP.

PJP is categorized as Health & Biotech Equities, while RSP is S&P 500. PJP tracks Dynamic Pharmaceuticals Intellidex Index, while RSP tracks S&P 500 Equal Weight Index. Their fees differ too: 0.58% for PJP and 0.20% for RSP.

PJP currently has the higher Sharpe Ratio (2.13 vs 1.70), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for PJP and RSP

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer